Having successfully developed an online business model in Australia, RMA Global (ASX: RMY) has ramped up penetration of the lucrative US market with RateMyAgent, their reviews platform for real estate agents, since launching a strong marketing push in March 2020. The platform has now advanced in the US to have more than 60,000 real estate
Read More
With the price of gold reaching all-time highs, mining services provider Swick (ASX: SWK) is thriving having secured new contracts and extensions from some of Australia’s largest mining companies to take their order book to $244 million. Among their bigger contracts is an extension from Northern Star Resources (ASX: NST) at their West Australian Jundee
Read More
Despite the economic impact of COVID-19, fintech and payments company Novatti Group (ASX: NOV) has reported record revenues for the quarter to deliver $3.05m (unaudited). Managing Director, Peter Cook provided investors with a quick video update on Novatti’s thriving payments business and plans for the upcoming year where the Company is well funded for growth
Read More
Medtech company Osprey Medical (ASX: OSP) has significantly increased its global distribution network having secured distribution of their kidney imaging portfolio by partnering with global giant GE Healthcare. Under the 4-year agreement, GE will commercialise Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney for imaging, and will assist medical professionals
Read More
The Consumer Price Index (CPI) fell 1.9% in the June 2020 quarter according to the Australian Bureau of Statistics (ABS), with an annual deflation rate of 0.3%. Since 1949, this was only the third time annual inflation has been negative. The previous times were in 1962 and 1997-98. The June quarter fall was mainly the
Read More
Australians suffering from insomnia could soon have relief from the disorder with SUDA Pharmaceuticals (ASX: SUD) gaining approval from the Therapeutics Goods Administration (TGA) for the sale of their ZolpiMist spray as a treatment for short-term insomnia. The regulatory approval enables ZolpiMist to be sold in Australia and will assist their strategic partners in other
Read More
Australian health and biotech company Cellmid (ASX: CDY) is set to capitalise on rising health product retail sales in the United States having secured an exclusive distribution partnership with Tru Beauty Concepts and their network of 40,000 hair salons. The 5-year distribution deal will provide Cellmid with access to Tru Beauty salons across 11 US
Read More
Having successfully fulfilled various Government deals as a subcontractor, cybersecurity company WhiteHawk (ASX: WHK) is stepping up their game having won a 5-year US Federal contract as a prime supplier. The deal is valued at USD $580,000 per annum with an additional $600,000 per annum Option available if the Government elects to increase their cybersecurity
Read More
While the number of companies set to list on the ASX is still quieter than usual, we are continuing to see many healthcare companies viewing COVID-19 as an opportunity to make their public debut. 4D Medical are a Melbourne-based medical technology company, who have spent the last 15 years developing lung imaging software. The ‘software
Read More
Amid the raging situation in Victoria with rising COVID-19 cases in aged care facilities, tech company InteliCare (ASX: ICR) has secured a cornerstone order for their aged and disability care system which enables families to monitor loved ones contact-free, without invading their privacy. The order for 120 InteliLiving Systems was placed by independent care provider
Read More
